{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:16:21Z","timestamp":1794975381400,"version":"4.9.1"},"reference-count":243,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41581-025-00958-x","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T09:04:48Z","timestamp":1745312688000},"page":"464-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Innate immune cells in acute and chronic kidney disease"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-561X","authenticated-orcid":false,"given":"Xiao-ming","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nikolic-Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-9755","authenticated-orcid":false,"given":"Hui-Yao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"958_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin, A. et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns. Kidney Int. 105, 684\u2013701 (2024).","journal-title":"Kidney Int."},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"Collaboration, G. B. D. C. K. D. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"958_CR3","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1\u2013138 (2012)."},{"key":"958_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste, E. A. J. et al. Global epidemiology and outcomes of acute kidney injury. Nat. Rev. Nephrol. 14, 607\u2013625 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum, J. A. et al. Acute kidney injury. Nat. Rev. Dis. Prim. 7, 52 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","volume":"97","author":"AS Levey","year":"2020","unstructured":"Levey, A. S. et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 97, 1117\u20131129 (2020).","journal-title":"Kidney Int."},{"key":"958_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med. 371, 58\u201366 (2014).","journal-title":"N. Engl. J. Med."},{"key":"958_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000516647","volume":"146","author":"AS Levey","year":"2022","unstructured":"Levey, A. S. Defining AKD: the spectrum of AKI, AKD, and CKD. Nephron 146, 302\u2013305 (2022).","journal-title":"Nephron"},{"key":"958_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442\u2013448 (2012).","journal-title":"Kidney Int."},{"key":"958_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1795","volume":"2","author":"MT James","year":"2019","unstructured":"James, M. T. et al. Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system. JAMA Netw. Open. 2, e191795 (2019).","journal-title":"JAMA Netw. Open."},{"key":"958_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1352-z","volume":"20","author":"JB O\u2019Neal","year":"2016","unstructured":"O\u2019Neal, J. B., Shaw, A. D. & Billings, F. T. t. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit. Care 20, 187 (2016).","journal-title":"Crit. Care"},{"key":"958_CR12","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","volume":"18","author":"T Speer","year":"2022","unstructured":"Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D. & Ridker, P. M. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat. Rev. Nephrol. 18, 762\u2013778 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/s41423-024-01190-6","volume":"21","author":"Q Ouyang","year":"2024","unstructured":"Ouyang, Q. et al. Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis. Cell Mol. Immunol. 21, 826\u2013841 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"958_CR14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1681\/ASN.2020121723","volume":"32","author":"S Hasegawa","year":"2021","unstructured":"Hasegawa, S. et al. Activation of sympathetic signaling in macrophages blocks systemic inflammation and protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 32, 1599\u20131615 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","volume":"16","author":"SCW Tang","year":"2020","unstructured":"Tang, S. C. W. & Yiu, W. H. Innate immunity in diabetic kidney disease. Nat. Rev. Nephrol. 16, 206\u2013222 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.kint.2020.11.023","volume":"99","author":"R Wang","year":"2021","unstructured":"Wang, R., Wang, Y., Harris, D. C. H. & Cao, Q. Innate lymphoid cells in kidney diseases. Kidney Int. 99, 1077\u20131087 (2021).","journal-title":"Kidney Int."},{"key":"958_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103675","volume":"9","author":"W Yao","year":"2022","unstructured":"Yao, W. et al. Single cell RNA sequencing identifies a unique inflammatory macrophage subset as a druggable target for alleviating acute kidney injury. Adv. Sci. 9, e2103675 (2022).","journal-title":"Adv. Sci."},{"key":"958_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1182\/blood-2017-03-773374","volume":"130","author":"JS Dahlin","year":"2017","unstructured":"Dahlin, J. S. et al. KIT signaling is dispensable for human mast cell progenitor development. Blood 130, 1785\u20131794 (2017).","journal-title":"Blood"},{"key":"958_CR19","doi-asserted-by":"publisher","first-page":"2378520","DOI":"10.1080\/2162402X.2024.2378520","volume":"13","author":"C Cantoni","year":"2024","unstructured":"Cantoni, C. et al. Human NK cells and cancer. Oncoimmunology 13, 2378520 (2024).","journal-title":"Oncoimmunology"},{"key":"958_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","volume":"20","author":"DI Godfrey","year":"2019","unstructured":"Godfrey, D. I., Koay, H. F., McCluskey, J. & Gherardin, N. A. The biology and functional importance of MAIT cells. Nat. Immunol. 20, 1110\u20131128 (2019).","journal-title":"Nat. Immunol."},{"key":"958_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41577-020-0391-5","volume":"21","author":"SR Paludan","year":"2021","unstructured":"Paludan, S. R., Pradeu, T., Masters, S. L. & Mogensen, T. H. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137\u2013150 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","volume":"618","author":"T Lazarov","year":"2023","unstructured":"Lazarov, T., Juarez-Carreno, S., Cox, N. & Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature 618, 698\u2013707 (2023).","journal-title":"Nature"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani, A. & Garlanda, C. Humoral innate immunity and acute-phase proteins. N. Engl. J. Med. 388, 439\u2013452 (2023).","journal-title":"N. Engl. J. Med."},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li, D. & Wu, M. Pattern recognition receptors in health and diseases. Signal. Transduct. Target. Ther. 6, 291 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"958_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma, M., Jiang, W. & Zhou, R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity 57, 752\u2013771 (2024).","journal-title":"Immunity"},{"key":"958_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41422-020-0295-8","volume":"30","author":"S Christgen","year":"2020","unstructured":"Christgen, S., Place, D. E. & Kanneganti, T. D. Toward targeting inflammasomes: insights into their regulation and activation. Cell Res. 30, 315\u2013327 (2020).","journal-title":"Cell Res."},{"key":"958_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2023","unstructured":"Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595\u2013600 (2023).","journal-title":"Nature"},{"key":"958_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu, J. & Wu, H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu. Rev. Immunol. 41, 301\u2013316 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"958_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41423-022-00962-2","volume":"20","author":"CG Hsu","year":"2023","unstructured":"Hsu, C. G., Li, W., Sowden, M., Chavez, C. L. & Berk, B. C. Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages. Cell Mol. Immunol. 20, 131\u2013142 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"958_CR30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","volume":"44","author":"MM Gaidt","year":"2016","unstructured":"Gaidt, M. M. et al. Human monocytes engage an alternative inflammasome pathway. Immunity 44, 833\u2013846 (2016).","journal-title":"Immunity"},{"key":"958_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","volume":"21","author":"TJ Guzik","year":"2024","unstructured":"Guzik, T. J., Nosalski, R., Maffia, P. & Drummond, G. R. Immune and inflammatory mechanisms in hypertension. Nat. Rev. Cardiol. 21, 396\u2013416 (2024).","journal-title":"Nat. Rev. Cardiol."},{"key":"958_CR32","doi-asserted-by":"publisher","first-page":"114447","DOI":"10.1016\/j.biopha.2023.114447","volume":"161","author":"GR Saranya","year":"2023","unstructured":"Saranya, G. R. & Viswanathan, P. Gut microbiota dysbiosis in AKI to CKD transition. Biomed. Pharmacother. 161, 114447 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"958_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01826-9","volume":"12","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome. Microbiome 12, 109 (2024).","journal-title":"Microbiome"},{"key":"958_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","volume":"104","author":"J Barratt","year":"2023","unstructured":"Barratt, J. et al. IgA nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int. 104, 254\u2013264 (2023).","journal-title":"Kidney Int."},{"key":"958_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.kint.2017.01.014","volume":"92","author":"S Tanaka","year":"2017","unstructured":"Tanaka, S. et al. Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia\/reperfusion injury. Kidney Int. 92, 154\u2013164 (2017).","journal-title":"Kidney Int."},{"key":"958_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.kint.2017.01.009","volume":"92","author":"B Deng","year":"2017","unstructured":"Deng, B. et al. The leukotriene B4-leukotriene B4 receptor axis promotes cisplatin-induced acute kidney injury by modulating neutrophil recruitment. Kidney Int. 92, 89\u2013100 (2017).","journal-title":"Kidney Int."},{"key":"958_CR37","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ajpath.2016.04.007","volume":"186","author":"J Ryan","year":"2016","unstructured":"Ryan, J., Kanellis, J., Blease, K., Ma, F. Y. & Nikolic-Paterson, D. J. Spleen tyrosine kinase signaling promotes myeloid cell recruitment and kidney damage after renal ischemia\/reperfusion injury. Am. J. Pathol. 186, 2032\u20132042 (2016).","journal-title":"Am. J. Pathol."},{"key":"958_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","volume":"19","author":"V Petr","year":"2023","unstructured":"Petr, V. & Thurman, J. M. The role of complement in kidney disease. Nat. Rev. Nephrol. 19, 771\u2013787 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.kint.2018.12.007","volume":"95","author":"M Meissner","year":"2019","unstructured":"Meissner, M., Viehmann, S. F. & Kurts, C. DAMPening sterile inflammation of the kidney. Kidney Int. 95, 489\u2013491 (2019).","journal-title":"Kidney Int."},{"key":"958_CR40","doi-asserted-by":"crossref","unstructured":"Vazquez-Carballo, C. et al. Toll-like receptors in acute kidney injury. Int J Mol Sci 22, 816 (2021).","DOI":"10.3390\/ijms22020816"},{"key":"958_CR41","doi-asserted-by":"publisher","first-page":"109467","DOI":"10.1016\/j.intimp.2022.109467","volume":"114","author":"X Huang","year":"2023","unstructured":"Huang, X., Yu, Q., Zhang, L. & Jiang, Z. Research progress on Mincle as a multifunctional receptor. Int. Immunopharmacol. 114, 109467 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"958_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.kint.2016.10.020","volume":"91","author":"LL Lv","year":"2017","unstructured":"Lv, L. L. et al. The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation. Kidney Int. 91, 587\u2013602 (2017).","journal-title":"Kidney Int."},{"key":"958_CR43","doi-asserted-by":"publisher","first-page":"1385696","DOI":"10.3389\/fimmu.2024.1385696","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease. Front. Immunol. 15, 1385696 (2024).","journal-title":"Front. Immunol."},{"key":"958_CR44","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.kint.2017.08.014","volume":"93","author":"WM Raup-Konsavage","year":"2018","unstructured":"Raup-Konsavage, W. M. et al. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia\/reperfusion-induced acute kidney injury. Kidney Int. 93, 365\u2013374 (2018).","journal-title":"Kidney Int."},{"key":"958_CR45","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1681\/ASN.2016080925","volume":"28","author":"D Nakazawa","year":"2017","unstructured":"Nakazawa, D. et al. Histones and neutrophil extracellular traps enhance tubular necrosis and remote organ injury in ischemic AKI. J. Am. Soc. Nephrol. 28, 1753\u20131768 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR46","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/ndt\/gfae014","volume":"39","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. GSDMD and GSDME synergy in the transition of acute kidney injury to chronic kidney disease. Nephrol. Dial. Transpl. 39, 1344\u20131359 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"958_CR47","doi-asserted-by":"crossref","unstructured":"Loh, W. & Vermeren, S. Anti-inflammatory neutrophil functions in the resolution of inflammation and tissue repair. Cells 11, 4076 (2022).","DOI":"10.3390\/cells11244076"},{"key":"958_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00011-024-01885-6","volume":"73","author":"GP Suchitha","year":"2024","unstructured":"Suchitha, G. P., Devasahayam Arokia Balaya, R., Prasad, T. S. K. & Dagamajalu, S. A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule. Inflamm. Res. 73, 1099\u20131106 (2024).","journal-title":"Inflamm. Res."},{"key":"958_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","volume":"15","author":"D Nakazawa","year":"2019","unstructured":"Nakazawa, D., Masuda, S., Tomaru, U. & Ishizu, A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat. Rev. Rheumatol. 15, 91\u2013101 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"958_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01681-z","volume":"22","author":"J Shen","year":"2024","unstructured":"Shen, J. et al. Gasdermin D deficiency aborts myeloid calcium influx to drive granulopoiesis in lupus nephritis. Cell Commun. Signal. 22, 308 (2024).","journal-title":"Cell Commun. Signal."},{"key":"958_CR51","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/labinvest.2011.137","volume":"91","author":"J Ryan","year":"2011","unstructured":"Ryan, J. et al. Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis. Lab. Invest. 91, 1727\u20131738 (2011).","journal-title":"Lab. Invest."},{"key":"958_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/path.4598","volume":"238","author":"J Ryan","year":"2016","unstructured":"Ryan, J. et al. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase. J. Pathol. 238, 10\u201320 (2016).","journal-title":"J. Pathol."},{"key":"958_CR53","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1681\/ASN.2016121271","volume":"28","author":"DJ Caster","year":"2017","unstructured":"Caster, D. J., Powell, D. W., Miralda, I., Ward, R. A. & McLeish, K. R. Re-examining neutrophil participation in GN. J. Am. Soc. Nephrol. 28, 2275\u20132289 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR54","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1136\/annrheumdis-2018-213223","volume":"77","author":"E Pieterse","year":"2018","unstructured":"Pieterse, E. et al. Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation. Ann. Rheum. Dis. 77, 1790\u20131798 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"958_CR55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.123.321750","volume":"132","author":"M Thakur","year":"2023","unstructured":"Thakur, M. et al. NETs-induced thrombosis impacts on cardiovascular and chronic kidney disease. Circ. Res. 132, 933\u2013949 (2023).","journal-title":"Circ. Res."},{"key":"958_CR56","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/rheumatology\/key067","volume":"57","author":"M van der Linden","year":"2018","unstructured":"van der Linden, M. et al. Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome. Rheumatology 57, 1228\u20131234 (2018).","journal-title":"Rheumatology"},{"key":"958_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/annrheumdis-2018-213181","volume":"78","author":"E Frangou","year":"2019","unstructured":"Frangou, E. et al. REDD1\/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A). Ann. Rheum. Dis. 78, 238\u2013248 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"958_CR58","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.kint.2024.03.010","volume":"105","author":"Y Ueda","year":"2024","unstructured":"Ueda, Y. et al. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 105, 1291\u20131305 (2024).","journal-title":"Kidney Int."},{"key":"958_CR59","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92920","volume":"2","author":"D Kienhofer","year":"2017","unstructured":"Kienhofer, D. et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight 2, e92920 (2017).","journal-title":"JCI Insight"},{"key":"958_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36522-z","volume":"14","author":"N Miao","year":"2023","unstructured":"Miao, N. et al. Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus. Nat. Commun. 14, 872 (2023).","journal-title":"Nat. Commun."},{"key":"958_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16158-z","volume":"11","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat. Commun. 11, 2280 (2020).","journal-title":"Nat. Commun."},{"key":"958_CR62","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2011.217","volume":"80","author":"HJ Anders","year":"2011","unstructured":"Anders, H. J. & Ryu, M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 80, 915\u2013925 (2011).","journal-title":"Kidney Int."},{"key":"958_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309752","volume":"11","author":"YL Zhang","year":"2024","unstructured":"Zhang, Y. L. et al. Identification of a novel ECM remodeling macrophage subset in AKI to CKD transition by integrative spatial and single-cell analysis. Adv. Sci. 11, e2309752 (2024).","journal-title":"Adv. Sci."},{"key":"958_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM Tang","year":"2019","unstructured":"Tang, P. M., Nikolic-Paterson, D. J. & Lan, H. Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat. Rev. Nephrol. 15, 144\u2013158 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR65","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ki.2012.207","volume":"82","author":"DA Ferenbach","year":"2012","unstructured":"Ferenbach, D. A. et al. Macrophage\/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia\/reperfusion injury in mice. Kidney Int. 82, 928\u2013933 (2012).","journal-title":"Kidney Int."},{"key":"958_CR66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220525","volume":"220","author":"S Culemann","year":"2023","unstructured":"Culemann, S. et al. Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes. J. Exp. Med. 220, e20220525 (2023).","journal-title":"J. Exp. Med."},{"key":"958_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/ijbs.80200","volume":"19","author":"RZ Tan","year":"2023","unstructured":"Tan, R. Z. et al. Neuropeptide Y protects kidney from acute kidney injury by inactivating M1 macrophages via the Y1R-NF-\u03baB-Mincle-dependent mechanism. Int. J. Biol. Sci. 19, 521\u2013536 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"958_CR68","doi-asserted-by":"crossref","unstructured":"Huang, W. et al. JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism. JCI Insight 7, e158571 (2022).","DOI":"10.1172\/jci.insight.158571"},{"key":"958_CR69","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.kint.2023.04.013","volume":"104","author":"S Li","year":"2023","unstructured":"Li, S. et al. Peroxiredoxin 1 aggravates acute kidney injury by promoting inflammation through Mincle\/Syk\/NF-\u03baB signaling. Kidney Int. 104, 305\u2013323 (2023).","journal-title":"Kidney Int."},{"key":"958_CR70","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200644R","volume":"37","author":"L Yuan","year":"2023","unstructured":"Yuan, L. et al. Macrophage-derived exosomal miR-195a-5p impairs tubular epithelial cells mitochondria in acute kidney injury mice. FASEB J. 37, e22691 (2023).","journal-title":"FASEB J."},{"key":"958_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-023-00957-9","volume":"30","author":"Y Jiao","year":"2023","unstructured":"Jiao, Y. et al. Exosomal PGE2 from M2 macrophages inhibits neutrophil recruitment and NET formation through lipid mediator class switching in sepsis. J. Biomed. Sci. 30, 62 (2023).","journal-title":"J. Biomed. Sci."},{"key":"958_CR72","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1111\/jcmm.14234","volume":"23","author":"JH Li","year":"2019","unstructured":"Li, J. H. et al. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion. J. Cell Mol. Med. 23, 3867\u20133877 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"958_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41420-022-00859-z","volume":"8","author":"T Li","year":"2022","unstructured":"Li, T. et al. Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI. Cell Death Discov. 8, 61 (2022).","journal-title":"Cell Death Discov."},{"key":"958_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4886","volume":"10","author":"C Stoppe","year":"2018","unstructured":"Stoppe, C. et al. The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci. Transl. Med. 10, eaan4886 (2018).","journal-title":"Sci. Transl. Med."},{"key":"958_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-physiol-022516-034219","volume":"79","author":"SC Huen","year":"2017","unstructured":"Huen, S. C. & Cantley, L. G. Macrophages in renal injury and repair. Annu. Rev. Physiol. 79, 449\u2013469 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"958_CR76","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1172\/JCI60363","volume":"122","author":"MZ Zhang","year":"2012","unstructured":"Zhang, M. Z. et al. CSF-1 signaling mediates recovery from acute kidney injury. J. Clin. Invest. 122, 4519\u20134532 (2012).","journal-title":"J. Clin. Invest."},{"key":"958_CR77","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2021121548","volume":"33","author":"NS Shin","year":"2022","unstructured":"Shin, N. S. et al. Arginase-1 is required for macrophage-mediated renal tubule regeneration. J. Am. Soc. Nephrol. 33, 1077\u20131086 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR78","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1681\/ASN.2013020152","volume":"25","author":"M Lech","year":"2014","unstructured":"Lech, M. et al. Macrophage phenotype controls long-term AKI outcomes-kidney regeneration versus atrophy. J. Am. Soc. Nephrol. 25, 292\u2013304 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR79","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1681\/ASN.2020091373","volume":"32","author":"SR Kim","year":"2021","unstructured":"Kim, S. R. et al. Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy. J. Am. Soc. Nephrol. 32, 1987\u20132004 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32634-0","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu, L., Guo, J., Moledina, D. G. & Cantley, L. G. Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition. Nat. Commun. 13, 4892 (2022).","journal-title":"Nat. Commun."},{"key":"958_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1681\/ASN.2019020113","volume":"31","author":"R Kormann","year":"2020","unstructured":"Kormann, R. et al. Periostin promotes cell proliferation and macrophage polarization to drive repair after AKI. J. Am. Soc. Nephrol. 31, 85\u2013100 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR82","doi-asserted-by":"publisher","first-page":"F477","DOI":"10.1152\/ajprenal.00624.2012","volume":"305","author":"SC Huen","year":"2013","unstructured":"Huen, S. C., Moeckel, G. W. & Cantley, L. G. Macrophage-specific deletion of transforming growth factor-beta1 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury. Am. J. Physiol. Renal Physiol. 305, F477\u2013F484 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR83","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1681\/ASN.2014040320","volume":"26","author":"J Belliere","year":"2015","unstructured":"Belliere, J. et al. Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury. J. Am. Soc. Nephrol. 26, 1363\u20131377 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.402","volume":"7","author":"XM Meng","year":"2016","unstructured":"Meng, X. M. et al. Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. Cell Death Dis. 7, e2495 (2016).","journal-title":"Cell Death Dis."},{"key":"958_CR85","doi-asserted-by":"publisher","DOI":"10.1097\/IMNA-D-23-00001","volume":"10","author":"JY Chung","year":"2023","unstructured":"Chung, J. Y. et al. Immunodynamics of macrophages in renal fibrosis. Integr. Med. Nephrol. Androl. 10, e00001 (2023).","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"958_CR86","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/sj.ki.5000212","volume":"69","author":"KS Eardley","year":"2006","unstructured":"Eardley, K. S. et al. The relationship between albuminuria, MCP-1\/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int. 69, 1189\u20131197 (2006).","journal-title":"Kidney Int."},{"key":"958_CR87","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1681\/ASN.2021060815","volume":"32","author":"D Xie","year":"2021","unstructured":"Xie, D. et al. Intensity of macrophage infiltration in glomeruli predicts response to immunosuppressive therapy in patients with IgA nephropathy. J. Am. Soc. Nephrol. 32, 3187\u20133196 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR88","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/ndt\/gfi105","volume":"20","author":"Y Ikezumi","year":"2005","unstructured":"Ikezumi, Y. et al. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol. Dial. Transpl. 20, 2704\u20132713 (2005).","journal-title":"Nephrol. Dial. Transpl."},{"key":"958_CR89","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2559.2011.03742.x","volume":"58","author":"Y Ikezumi","year":"2011","unstructured":"Ikezumi, Y. et al. Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion. Histopathology 58, 198\u2013210 (2011).","journal-title":"Histopathology"},{"key":"958_CR90","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1681\/ASN.2019121285","volume":"31","author":"JM Mejia-Vilet","year":"2020","unstructured":"Mejia-Vilet, J. M. et al. Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis. J. Am. Soc. Nephrol. 31, 1335\u20131347 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR91","doi-asserted-by":"publisher","first-page":"102914","DOI":"10.1016\/j.jaut.2022.102914","volume":"133","author":"JP Aendekerk","year":"2022","unstructured":"Aendekerk, J. P. et al. CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis. J. Autoimmun. 133, 102914 (2022).","journal-title":"J. Autoimmun."},{"key":"958_CR92","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00467-020-04734-w","volume":"36","author":"Y Ikezumi","year":"2021","unstructured":"Ikezumi, Y. et al. Steroid treatment promotes an M2 anti-inflammatory macrophage phenotype in childhood lupus nephritis. Pediatr. Nephrol. 36, 349\u2013359 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"958_CR93","doi-asserted-by":"publisher","first-page":"F1043","DOI":"10.1152\/ajprenal.00389.2012","volume":"304","author":"Y Han","year":"2013","unstructured":"Han, Y., Ma, F. Y., Tesch, G. H., Manthey, C. L. & Nikolic-Paterson, D. J. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Am. J. Physiol. Renal Physiol. 304, F1043\u2013F1053 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR94","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00125-009-1399-3","volume":"52","author":"AK Lim","year":"2009","unstructured":"Lim, A. K. et al. Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db\/db mice. Diabetologia 52, 1669\u20131679 (2009).","journal-title":"Diabetologia"},{"key":"958_CR95","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2014.11.007","volume":"57","author":"SA Chalmers","year":"2015","unstructured":"Chalmers, S. A. et al. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. J. Autoimmun. 57, 42\u201352 (2015).","journal-title":"J. Autoimmun."},{"key":"958_CR96","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 10, 493\u2013503 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR97","doi-asserted-by":"publisher","first-page":"149997","DOI":"10.1016\/j.bbrc.2024.149997","volume":"715","author":"JK Peter","year":"2024","unstructured":"Peter, J. K. et al. Renal macrophages induce hypertension and kidney fibrosis in Angiotensin II salt mice model. Biochem. Biophys. Res. Commun. 715, 149997 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"958_CR98","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int. 83, 855\u2013864 (2013).","journal-title":"Kidney Int."},{"key":"958_CR99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.ki.5000014","volume":"69","author":"FY Chow","year":"2006","unstructured":"Chow, F. Y. et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 69, 73\u201380 (2006).","journal-title":"Kidney Int."},{"key":"958_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200668","volume":"9","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Single-cell RNA sequencing identified novel Nr4a1+ Ear2+ anti-inflammatory macrophage phenotype under myeloid-TLR4 dependent regulation in anti-glomerular basement membrane (GBM) crescentic glomerulonephritis (cGN). Adv. Sci. 9, e2200668 (2022).","journal-title":"Adv. Sci."},{"key":"958_CR101","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1007\/s00018-021-03936-1","volume":"78","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Regulatory role and mechanisms of myeloid TLR4 in anti-GBM glomerulonephritis. Cell Mol. Life Sci. 78, 6721\u20136734 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"958_CR102","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ki.2012.483","volume":"83","author":"MA Kluger","year":"2013","unstructured":"Kluger, M. A. et al. Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int. 83, 865\u2013877 (2013).","journal-title":"Kidney Int."},{"key":"958_CR103","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add6137","volume":"15","author":"HJ Paust","year":"2023","unstructured":"Paust, H. J. et al. CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12. Sci. Transl. Med. 15, eadd6137 (2023).","journal-title":"Sci. Transl. Med."},{"key":"958_CR104","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1523-1755.2003.00717.x","volume":"63","author":"Y Ikezumi","year":"2003","unstructured":"Ikezumi, Y., Hurst, L. A., Masaki, T., Atkins, R. C. & Nikolic-Paterson, D. J. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int. 63, 83\u201395 (2003).","journal-title":"Kidney Int."},{"key":"958_CR105","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/01.ASN.0000056604.13964.62","volume":"14","author":"Y Ikezumi","year":"2003","unstructured":"Ikezumi, Y., Atkins, R. C. & Nikolic-Paterson, D. J. Interferon-\u03b3 augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J. Am. Soc. Nephrol. 14, 888\u2013898 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR106","doi-asserted-by":"publisher","first-page":"1203062","DOI":"10.3389\/fimmu.2023.1203062","volume":"14","author":"M Shi","year":"2023","unstructured":"Shi, M. et al. Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. Front. Immunol. 14, 1203062 (2023).","journal-title":"Front. Immunol."},{"key":"958_CR107","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.kint.2022.08.026","volume":"102","author":"J Fu","year":"2022","unstructured":"Fu, J. et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 102, 1291\u20131304 (2022).","journal-title":"Kidney Int."},{"key":"958_CR108","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1681\/ASN.2020060806","volume":"31","author":"BR Conway","year":"2020","unstructured":"Conway, B. R. et al. Kidney single-cell atlas reveals myeloid heterogeneity in progression and regression of kidney disease. J. Am. Soc. Nephrol. 31, 2833\u20132854 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR109","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/ki.2013.135","volume":"84","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int. 84, 745\u2013755 (2013).","journal-title":"Kidney Int."},{"key":"958_CR110","doi-asserted-by":"publisher","first-page":"1153300","DOI":"10.1155\/2022\/1153300","volume":"2022","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. M2c macrophages protect mice from adriamycin-induced nephropathy by upregulating CD62L in Tregs. Mediators Inflamm. 2022, 1153300 (2022).","journal-title":"Mediators Inflamm."},{"key":"958_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23440-1","volume":"12","author":"N Ding","year":"2022","unstructured":"Ding, N. et al. Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy. Sci. Rep. 12, 18558 (2022).","journal-title":"Sci. Rep."},{"key":"958_CR112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2016.00008","volume":"7","author":"A Bruchfeld","year":"2016","unstructured":"Bruchfeld, A., Wendt, M. & Miller, E. J. Macrophage migration inhibitory factor in clinical kidney disease. Front. Immunol. 7, 8 (2016).","journal-title":"Front. Immunol."},{"key":"958_CR113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","volume":"57","author":"SS Jankauskas","year":"2019","unstructured":"Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S. & Boor, P. Evolving complexity of MIF signaling. Cell Signal. 57, 76\u201388 (2019).","journal-title":"Cell Signal."},{"key":"958_CR114","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF03401748","volume":"4","author":"N Yang","year":"1998","unstructured":"Yang, N. et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production. Mol. Med. 4, 413\u2013424 (1998).","journal-title":"Mol. Med."},{"key":"958_CR115","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4049\/jimmunol.1001767","volume":"186","author":"L Leng","year":"2011","unstructured":"Leng, L. et al. A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB\/NZW F1 and MRL\/lpr mice. J. Immunol. 186, 527\u2013538 (2011).","journal-title":"J. Immunol."},{"key":"958_CR116","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","volume":"17","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S. J., Floege, J., Fliser, D. & Speer, T. WNT-\u03b2-catenin signalling \u2014 a versatile player in kidney injury and repair. Nat. Rev. Nephrol. 17, 172\u2013184 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR117","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.7150\/ijbs.94166","volume":"20","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. Myeloid-derived Wnts play an indispensible role in macrophage and fibroblast activation and kidney fibrosis. Int. J. Biol. Sci. 20, 2310\u20132322 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"958_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44886-z","volume":"15","author":"C Cohen","year":"2024","unstructured":"Cohen, C. et al. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease. Nat. Commun. 15, 743 (2024).","journal-title":"Nat. Commun."},{"key":"958_CR119","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.0912228107","volume":"107","author":"SL Lin","year":"2010","unstructured":"Lin, S. L. et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc. Natl Acad. Sci. USA 107, 4194\u20134199 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"958_CR120","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2147\/IJN.S449388","volume":"19","author":"Y Song","year":"2024","unstructured":"Song, Y. et al. Macrophage-derived exosomes as advanced therapeutics for inflammation: current progress and future perspectives. Int. J. Nanomed. 19, 1597\u20131627 (2024).","journal-title":"Int. J. Nanomed."},{"key":"958_CR121","doi-asserted-by":"publisher","first-page":"121991","DOI":"10.1016\/j.lfs.2023.121991","volume":"330","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy. Life Sci. 330, 121991 (2023).","journal-title":"Life Sci."},{"key":"958_CR122","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200550RR","volume":"36","author":"J Zhao","year":"2022","unstructured":"Zhao, J., Chen, J., Zhu, W., Qi, X. M. & Wu, Y. G. Exosomal miR-7002-5p derived from highglucose-induced macrophages suppresses autophagy in tubular epithelial cells by targeting Atg9b. FASEB J. 36, e22501 (2022).","journal-title":"FASEB J."},{"key":"958_CR123","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells12010161","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. High-phosphate-stimulated macrophage-derived exosomes promote vascular calcification via let-7b-5p\/TGFBR1 axis in chronic kidney disease. Cells 12, 161 (2022).","journal-title":"Cells"},{"key":"958_CR124","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/iub.2393","volume":"72","author":"H Huang","year":"2020","unstructured":"Huang, H. et al. M2 macrophage-derived exosomal miR-25-3p improves high glucose-induced podocytes injury through activation autophagy via inhibiting DUSP1 expression. IUBMB Life 72, 2651\u20132662 (2020).","journal-title":"IUBMB Life"},{"key":"958_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01708-5","volume":"22","author":"Q Yin","year":"2024","unstructured":"Yin, Q. et al. Macrophage-derived exosomes promote telomere fragility and senescence in tubular epithelial cells by delivering miR-155. Cell Commun. Signal. 22, 357 (2024).","journal-title":"Cell Commun. Signal."},{"key":"958_CR126","doi-asserted-by":"publisher","first-page":"8809","DOI":"10.18632\/oncotarget.6604","volume":"7","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. TGF-\u03b2\/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Oncotarget 7, 8809\u20138822 (2016).","journal-title":"Oncotarget"},{"key":"958_CR127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/2773-0387.358225","volume":"9","author":"HY Lan","year":"2022","unstructured":"Lan, H. Y. Macrophage-myofibroblast transition in kidney disease. Integr. Med. Nephrol. Androl. 9, 12 (2022).","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"958_CR128","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.1073\/pnas.1917663117","volume":"117","author":"PM Tang","year":"2020","unstructured":"Tang, P. M. et al. Neural transcription factor Pou4f1 promotes renal fibrosis via macrophage-myofibroblast transition. Proc. Natl Acad. Sci. USA 117, 20741\u201320752 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"958_CR129","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1681\/ASN.2016050573","volume":"28","author":"YY Wang","year":"2017","unstructured":"Wang, Y. Y. et al. Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J. Am. Soc. Nephrol. 28, 2053\u20132067 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR130","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99561","volume":"3","author":"R Kramann","year":"2018","unstructured":"Kramann, R. et al. Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis. JCI Insight 3, e99561 (2018).","journal-title":"JCI Insight"},{"key":"958_CR131","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","volume":"30","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition. Mol. Ther. 30, 3017\u20133033 (2022).","journal-title":"Mol. Ther."},{"key":"958_CR132","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe, C. et al. Decoding myofibroblast origins in human kidney fibrosis. Nature 589, 281\u2013286 (2021).","journal-title":"Nature"},{"key":"958_CR133","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41581-020-0272-y","volume":"16","author":"C Kurts","year":"2020","unstructured":"Kurts, C., Ginhoux, F. & Panzer, U. Kidney dendritic cells: fundamental biology and functional roles in health and disease. Nat. Rev. Nephrol. 16, 391\u2013407 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR134","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1681\/ASN.2009040407","volume":"21","author":"RK Tadagavadi","year":"2010","unstructured":"Tadagavadi, R. K. & Reeves, W. B. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J. Am. Soc. Nephrol. 21, 53\u201363 (2010).","journal-title":"J. Am. Soc. Nephrol"},{"key":"958_CR135","doi-asserted-by":"publisher","first-page":"1294807","DOI":"10.3389\/fimmu.2024.1294807","volume":"15","author":"D Lv","year":"2024","unstructured":"Lv, D. et al. Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury. Front. Immunol. 15, 1294807 (2024).","journal-title":"Front. Immunol."},{"key":"958_CR136","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3389\/fimmu.2019.02418","volume":"10","author":"H Dai","year":"2019","unstructured":"Dai, H., Thomson, A. W. & Rogers, N. M. Dendritic cells as sensors, mediators, and regulators of ischemic injury. Front. Immunol. 10, 2418 (2019).","journal-title":"Front. Immunol."},{"key":"958_CR137","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.kint.2023.05.008","volume":"104","author":"JSY Li","year":"2023","unstructured":"Li, J. S. Y. et al. Tolerogenic dendritic cells protect against acute kidney injury. Kidney Int. 104, 492\u2013507 (2023).","journal-title":"Kidney Int."},{"key":"958_CR138","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1681\/ASN.0000000000000027","volume":"34","author":"J Qu","year":"2023","unstructured":"Qu, J. et al. Hypoxia-inducible factor 2\u0251 attenuates renal ischemia-reperfusion injury by suppressing CD36-mediated lipid accumulation in dendritic cells in a mouse model. J. Am. Soc. Nephrol. 34, 73\u201387 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR139","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1096\/fj.201903222RR","volume":"34","author":"P Jia","year":"2020","unstructured":"Jia, P. et al. Depletion of miR-21 in dendritic cells aggravates renal ischemia-reperfusion injury. FASEB J. 34, 11729\u201311740 (2020).","journal-title":"FASEB J."},{"key":"958_CR140","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1172\/JCI63170","volume":"122","author":"L Li","year":"2012","unstructured":"Li, L. et al. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin. Invest. 122, 3931\u20133942 (2012).","journal-title":"J Clin. Invest."},{"key":"958_CR141","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1097\/TP.0000000000003765","volume":"105","author":"J Li","year":"2021","unstructured":"Li, J., Thomson, A. W. & Rogers, N. M. Myeloid and mesenchymal stem cell therapies for solid organ transplant tolerance. Transplantation 105, e303\u2013e321 (2021).","journal-title":"Transplantation"},{"key":"958_CR142","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/ard-2023-224788","volume":"83","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis. Ann. Rheum. Dis. 83, 608\u2013623 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"958_CR143","doi-asserted-by":"publisher","first-page":"F1391","DOI":"10.1152\/ajprenal.00318.2013","volume":"305","author":"AJ Kassianos","year":"2013","unstructured":"Kassianos, A. J. et al. Increased tubulointerstitial recruitment of human CD141hi CLEC9A+ and CD1c+ myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease. Am. J. Physiol. Renal Physiol. 305, F1391\u2013F1401 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR144","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi, A. et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat. Immunol. 20, 902\u2013914 (2019).","journal-title":"Nat. Immunol."},{"key":"958_CR145","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/his.13803","volume":"74","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. High renal DC-SIGN+ cell density is associated with severe renal lesions and poor prognosis in patients with immunoglobulin A nephropathy. Histopathology 74, 744\u2013758 (2019).","journal-title":"Histopathology"},{"key":"958_CR146","doi-asserted-by":"publisher","first-page":"635212","DOI":"10.3389\/fimmu.2021.635212","volume":"12","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. Conventional type 1 dendritic cells (cDC1) in human kidney diseases: clinico-pathological correlations. Front. Immunol. 12, 635212 (2021).","journal-title":"Front. Immunol."},{"key":"958_CR147","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/ki.2011.471","volume":"81","author":"D Zheng","year":"2012","unstructured":"Zheng, D. et al. Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease. Kidney Int. 81, 892\u2013902 (2012).","journal-title":"Kidney Int."},{"key":"958_CR148","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1681\/ASN.2015030229","volume":"27","author":"Q Cao","year":"2016","unstructured":"Cao, Q. et al. CD103+ dendritic cells elicit CD8+ T cell responses to accelerate kidney injury in adriamycin nephropathy. J. Am. Soc. Nephrol. 27, 1344\u20131360 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR149","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/ndt\/gfy385","volume":"34","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation. Nephrol. Dial. Transpl. 34, 1853\u20131863 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"958_CR150","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1681\/ASN.2017030270","volume":"29","author":"S Brahler","year":"2018","unstructured":"Brahler, S. et al. Opposing roles of dendritic cell subsets in experimental GN. J. Am. Soc. Nephrol. 29, 138\u2013154 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR151","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","volume":"41","author":"ANJ McKenzie","year":"2014","unstructured":"McKenzie, A. N. J., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366\u2013374 (2014).","journal-title":"Immunity"},{"key":"958_CR152","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1681\/ASN.2014050479","volume":"26","author":"Q Huang","year":"2015","unstructured":"Huang, Q. et al. IL-25 elicits innate lymphoid cells and multipotent progenitor type 2 cells that reduce renal ischemic\/reperfusion injury. J. Am. Soc. Nephrol. 26, 2199\u20132211 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR153","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1681\/ASN.2017070774","volume":"29","author":"Q Cao","year":"2018","unstructured":"Cao, Q. et al. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 29, 961\u2013976 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR154","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fimmu.2019.00826","volume":"10","author":"GJM Cameron","year":"2019","unstructured":"Cameron, G. J. M. et al. Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury. Front. Immunol. 10, 826 (2019).","journal-title":"Front. Immunol."},{"key":"958_CR155","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1681\/ASN.2010091011","volume":"22","author":"A Akcay","year":"2011","unstructured":"Akcay, A. et al. IL-33 exacerbates acute kidney injury. J. Am. Soc. Nephrol. 22, 2057\u20132067 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR156","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.diabet.2017.06.008","volume":"44","author":"M Sehnine","year":"2018","unstructured":"Sehnine, M. et al. IL-33 receptor ST2 deficiency attenuates renal ischaemia-reperfusion injury in euglycaemic, but not streptozotocin-induced hyperglycaemic mice. Diabetes Metab. 44, 55\u201360 (2018).","journal-title":"Diabetes Metab."},{"key":"958_CR157","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1681\/ASN.2017060650","volume":"29","author":"M Ferhat","year":"2018","unstructured":"Ferhat, M. et al. Endogenous IL-33 contributes to kidney ischemia-reperfusion injury as an alarmin. J. Am. Soc. Nephrol. 29, 1272\u20131288 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR158","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/ni.3553","volume":"17","author":"F Vely","year":"2016","unstructured":"Vely, F. et al. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17, 1291\u20131299 (2016).","journal-title":"Nat. Immunol."},{"key":"958_CR159","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4049\/jimmunol.1901095","volume":"205","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. et al. Expansion of group 2 innate lymphoid cells in patients with end-stage renal disease and their clinical significance. J. Immunol. 205, 36\u201344 (2020).","journal-title":"J. Immunol."},{"key":"958_CR160","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13075-020-2114-5","volume":"22","author":"S Ryu","year":"2020","unstructured":"Ryu, S. et al. Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis. Arthritis Res. Ther. 22, 63 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"958_CR161","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.immuni.2024.05.004","volume":"57","author":"Z Liang","year":"2024","unstructured":"Liang, Z. et al. Intestinal CXCR6+ ILC3s migrate to the kidney and exacerbate renal fibrosis via IL-23 receptor signaling enhanced by PD-1 expression. Immunity 57, 1306\u20131323 e1308 (2024).","journal-title":"Immunity"},{"key":"958_CR162","doi-asserted-by":"publisher","first-page":"104828","DOI":"10.1016\/j.cellimm.2024.104828","volume":"401-402","author":"R Nagashima","year":"2024","unstructured":"Nagashima, R. et al. Group2 innate lymphoid cells ameliorate renal fibrosis and dysfunction associated with adenine-induced CKD. Cell Immunol. 401-402, 104828 (2024).","journal-title":"Cell Immunol."},{"key":"958_CR163","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fimmu.2019.00587","volume":"10","author":"JE Turner","year":"2019","unstructured":"Turner, J. E., Rickassel, C., Healy, H. & Kassianos, A. J. Natural killer cells in kidney health and disease. Front. Immunol. 10, 587 (2019).","journal-title":"Front. Immunol."},{"key":"958_CR164","first-page":"E13","volume":"109","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J. et al. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc. Natl Acad. Sci. USA 109, E13\u2013E22 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"958_CR165","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.4049\/jimmunol.1500651","volume":"195","author":"F Victorino","year":"2015","unstructured":"Victorino, F. et al. Tissue-resident NK cells mediate ischemic kidney injury and are not depleted by anti-asialo-GM1 antibody. J. Immunol. 195, 4973\u20134985 (2015).","journal-title":"J. Immunol."},{"key":"958_CR166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","volume":"92","author":"BMP Law","year":"2017","unstructured":"Law, B. M. P. et al. Interferon-\u03b3 production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression. Kidney Int. 92, 79\u201388 (2017).","journal-title":"Kidney Int."},{"key":"958_CR167","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1189\/jlb.4A0714-326R","volume":"97","author":"R Spada","year":"2015","unstructured":"Spada, R. et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J. Leukoc. Biol. 97, 583\u2013598 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"958_CR168","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2567.2008.02835.x","volume":"125","author":"E Postol","year":"2008","unstructured":"Postol, E. et al. Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB\/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF\/BLyS production. Immunology 125, 184\u2013196 (2008).","journal-title":"Immunology"},{"key":"958_CR169","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.4049\/jimmunol.2101012","volume":"208","author":"C Rickassel","year":"2022","unstructured":"Rickassel, C. et al. Conventional NK cells and type 1 innate lymphoid cells do not influence pathogenesis of experimental glomerulonephritis. J. Immunol. 208, 1585\u20131594 (2022).","journal-title":"J. Immunol."},{"key":"958_CR170","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/sj.ki.5000244","volume":"69","author":"G Zheng","year":"2006","unstructured":"Zheng, G. et al. NK cells do not mediate renal injury in murine adriamycin nephropathy. Kidney Int. 69, 1159\u20131165 (2006).","journal-title":"Kidney Int."},{"key":"958_CR171","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/ijms22010302","volume":"22","author":"S Vibhushan","year":"2020","unstructured":"Vibhushan, S. et al. Mast cell chymase and kidney disease. Int. J. Mol. Sci. 22, 302 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"958_CR172","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.4049\/jimmunol.1601282","volume":"198","author":"L Danelli","year":"2017","unstructured":"Danelli, L. et al. Early phase mast cell activation determines the chronic outcome of renal ischemia-reperfusion injury. J. Immunol. 198, 2374\u20132382 (2017).","journal-title":"J. Immunol."},{"key":"958_CR173","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1681\/ASN.2011020182","volume":"22","author":"SA Summers","year":"2011","unstructured":"Summers, S. A. et al. Mast cells mediate acute kidney injury through the production of TNF. J. Am. Soc. Nephrol. 22, 2226\u20132236 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR174","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000443437","volume":"41","author":"F Tong","year":"2016","unstructured":"Tong, F., Luo, L. & Liu, D. Effect of intervention in mast cell function before reperfusion on renal ischemia-reperfusion injury in rats. Kidney Blood Press. Res. 41, 335\u2013344 (2016).","journal-title":"Kidney Blood Press. Res."},{"key":"958_CR175","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2019.08.037","volume":"97","author":"LC Madjene","year":"2020","unstructured":"Madjene, L. C. et al. Mast cell chymase protects against acute ischemic kidney injury by limiting neutrophil hyperactivation and recruitment. Kidney Int. 97, 516\u2013527 (2020).","journal-title":"Kidney Int."},{"key":"958_CR176","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.21037\/tau.2018.11.03","volume":"8","author":"EP Owens","year":"2019","unstructured":"Owens, E. P. et al. Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease. Transl. Androl. Urol. 8, S175\u2013S183 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"958_CR177","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ki.2009.1","volume":"75","author":"DH Kim","year":"2009","unstructured":"Kim, D. H. et al. Mast cells decrease renal fibrosis in unilateral ureteral obstruction. Kidney Int. 75, 1031\u20131038 (2009).","journal-title":"Kidney Int."},{"key":"958_CR178","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molimm.2014.03.002","volume":"63","author":"LC Madjene","year":"2015","unstructured":"Madjene, L. C. et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol. Immunol. 63, 86\u201393 (2015).","journal-title":"Mol. Immunol."},{"key":"958_CR179","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.imlet.2003.11.014","volume":"91","author":"L Lin","year":"2004","unstructured":"Lin, L., Gerth, A. J. & Peng, S. L. Susceptibility of mast cell-deficient W\/Wv mice to pristane-induced experimental lupus nephritis. Immunol. Lett. 91, 93\u201397 (2004).","journal-title":"Immunol. Lett."},{"key":"958_CR180","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nm.2159","volume":"16","author":"N Charles","year":"2010","unstructured":"Charles, N., Hardwick, D., Daugas, E., Illei, G. G. & Rivera, J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 16, 701\u2013707 (2010).","journal-title":"Nat. Med."},{"key":"958_CR181","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41590-022-01200-7","volume":"23","author":"T Doke","year":"2022","unstructured":"Doke, T. et al. Single-cell analysis identifies the interaction of altered renal tubules with basophils orchestrating kidney fibrosis. Nat. Immunol. 23, 947\u2013959 (2022).","journal-title":"Nat. Immunol."},{"key":"958_CR182","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2215\/CJN.0000000000000277","volume":"18","author":"K Hattori","year":"2023","unstructured":"Hattori, K. et al. Interstitial eosinophilic aggregates and kidney outcome in patients with CKD. Clin. J. Am. Soc. Nephrol. 18, 1563\u20131572 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"958_CR183","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2010080815","volume":"22","author":"SH Yang","year":"2011","unstructured":"Yang, S. H. et al. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J. Am. Soc. Nephrol. 22, 1305\u20131314 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR184","doi-asserted-by":"publisher","first-page":"F618","DOI":"10.1152\/ajprenal.00160.2018","volume":"315","author":"T Uchida","year":"2018","unstructured":"Uchida, T. et al. Activated natural killer T cells in mice induce acute kidney injury with hematuria through possibly common mechanisms shared by human CD56+ T cells. Am. J. Physiol. Renal Physiol. 315, F618\u2013F627 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR185","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1681\/ASN.2018101064","volume":"30","author":"BMP Law","year":"2019","unstructured":"Law, B. M. P. et al. Human tissue-resident mucosal-associated invariant T (MAIT) cells in renal fibrosis and CKD. J. Am. Soc. Nephrol. 30, 1322\u20131335 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43269-0","volume":"14","author":"AC Gnirck","year":"2023","unstructured":"Gnirck, A. C. et al. Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease. Nat. Commun. 14, 7372 (2023).","journal-title":"Nat. Commun."},{"key":"958_CR187","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1158\/2159-8290.CD-24-0102","volume":"14","author":"SK Pal","year":"2024","unstructured":"Pal, S. K. et al. CD70-targeted allogeneic CAR T-cell therapy for advanced clear cell renal cell carcinoma. Cancer Discov. 14, 1176\u20131189 (2024).","journal-title":"Cancer Discov."},{"key":"958_CR188","doi-asserted-by":"publisher","first-page":"1454747","DOI":"10.3389\/fimmu.2024.1454747","volume":"15","author":"WH Robinson","year":"2024","unstructured":"Robinson, W. H. et al. Cutting-edge approaches to B-cell depletion in autoimmune diseases. Front. Immunol. 15, 1454747 (2024).","journal-title":"Front. Immunol."},{"key":"958_CR189","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","volume":"106","author":"M Vivarelli","year":"2024","unstructured":"Vivarelli, M. et al. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 106, 369\u2013391 (2024).","journal-title":"Kidney Int."},{"key":"958_CR190","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000492865","volume":"48","author":"M Cao","year":"2018","unstructured":"Cao, M. et al. Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury. Am. J. Nephrol. 48, 225\u2013233 (2018).","journal-title":"Am. J. Nephrol."},{"key":"958_CR191","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1053\/j.ajkd.2018.12.046","volume":"74","author":"P Ruggenenti","year":"2019","unstructured":"Ruggenenti, P. et al. C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial. Am. J. Kidney Dis. 74, 224\u2013238 (2019).","journal-title":"Kidney Dis."},{"key":"958_CR192","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","volume":"72","author":"M Le Quintrec","year":"2018","unstructured":"Le Quintrec, M. et al. Patterns of clinical response to eculizumab in patients with C3 glomerulopathy. Am. J. Kidney Dis. 72, 84\u201392 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"958_CR193","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.kint.2020.10.046","volume":"100","author":"G Ariceta","year":"2021","unstructured":"Ariceta, G. et al. The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment. Kidney Int. 100, 225\u2013237 (2021).","journal-title":"Kidney Int."},{"key":"958_CR194","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne, D. R. W., Merkel, P. A., Schall, T. J., Bekker, P. & Group, A. S. Avacopan for the treatment of ANCA-associated vasculitis. N. Engl. J. Med. 384, 599\u2013609 (2021).","journal-title":"N. Engl. J. Med."},{"key":"958_CR195","doi-asserted-by":"publisher","first-page":"ii29","DOI":"10.1093\/ndt\/gfad079","volume":"38","author":"B Wooden","year":"2023","unstructured":"Wooden, B., Tarragon, B., Navarro-Torres, M. & Bomback, A. S. Complement inhibitors for kidney disease. Nephrol. Dial. Transpl. 38, ii29\u2013ii39 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"958_CR196","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.kint.2023.09.027","volume":"105","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy. Kidney Int. 105, 189\u2013199 (2024).","journal-title":"Kidney Int."},{"key":"958_CR197","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.ekir.2022.07.004","volume":"7","author":"AS Bomback","year":"2022","unstructured":"Bomback, A. S. et al. Alternative complement pathway inhibition with iptacopan for the treatment of C3 glomerulopathy-study design of the APPEAR-C3G trial. Kidney Int. Rep. 7, 2150\u20132159 (2022).","journal-title":"Kidney Int. Rep."},{"key":"958_CR198","doi-asserted-by":"publisher","first-page":"F757","DOI":"10.1152\/ajprenal.00191.2021","volume":"321","author":"S Ito","year":"2021","unstructured":"Ito, S. et al. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 321, F757\u2013F770 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR199","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00316.2013","volume":"305","author":"T Sullivan","year":"2013","unstructured":"Sullivan, T. et al. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. Am. J. Physiol. Renal Physiol. 305, F1288\u2013F1297 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR200","doi-asserted-by":"publisher","first-page":"F372","DOI":"10.1152\/ajprenal.00131.2015","volume":"310","author":"S Kashyap","year":"2016","unstructured":"Kashyap, S. et al. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension. Am. J. Physiol. Renal Physiol. 310, F372\u2013F384 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR201","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1538\/expanim.23-0113","volume":"73","author":"X Wang","year":"2024","unstructured":"Wang, X., Xie, L. & Liu, C. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation. Exp. Anim. 73, 211\u2013222 (2024).","journal-title":"Exp. Anim."},{"key":"958_CR202","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","volume":"3","author":"D de Zeeuw","year":"2015","unstructured":"de Zeeuw, D. et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol. 3, 687\u2013696 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"958_CR203","doi-asserted-by":"publisher","first-page":"F1439","DOI":"10.1152\/ajprenal.00340.2019","volume":"317","author":"GH Tesch","year":"2019","unstructured":"Tesch, G. H., Pullen, N., Jesson, M. I., Schlerman, F. J. & Nikolic-Paterson, D. J. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in Nos3-deficient mice. Am. J. Physiol. Renal Physiol. 317, F1439\u2013F1449 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"958_CR204","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ekir.2018.07.010","volume":"3","author":"JD Gale","year":"2018","unstructured":"Gale, J. D. et al. Effect of PF-04634817, an Oral CCR2\/5 chemokine receptor antagonist, on albuminuria in adults with overt diabetic nephropathy. Kidney Int. Rep. 3, 1316\u20131327 (2018).","journal-title":"Kidney Int. Rep."},{"key":"958_CR205","doi-asserted-by":"publisher","first-page":"1502299","DOI":"10.3389\/fimmu.2024.1502299","volume":"15","author":"EO Gubernatorova","year":"2024","unstructured":"Gubernatorova, E. O. et al. Targeting inerleukin-6 for renoprotection. Front. Immunol. 15, 1502299 (2024).","journal-title":"Front. Immunol."},{"key":"958_CR206","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1681\/ASN.2020071106","volume":"32","author":"K Doberer","year":"2021","unstructured":"Doberer, K. et al. A randomized clinical trial of anti-IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection. J. Am. Soc. Nephrol. 32, 708\u2013722 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR207","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/TP.0000000000004285","volume":"107","author":"A Borski","year":"2023","unstructured":"Borski, A. et al. Anti-interleukin-6 antibody clazakizumab in antibody-mediated renal allograft rejection: accumulation of antibody-neutralized interleukin-6 without signs of proinflammatory rebound phenomena. Transplantation 107, 495\u2013503 (2023).","journal-title":"Transplantation"},{"key":"958_CR208","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.1993.70","volume":"43","author":"HY Lan","year":"1993","unstructured":"Lan, H. Y., Nikolic-Paterson, D. J., Zarama, M., Vannice, J. L. & Atkins, R. C. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int. 43, 479\u2013485 (1993).","journal-title":"Kidney Int."},{"key":"958_CR209","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","volume":"71","author":"PM Ridker","year":"2018","unstructured":"Ridker, P. M. et al. Inhibition of interleukin-1\u03b2 by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J. Am. Coll. Cardiol. 71, 2405\u20132414 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"958_CR210","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ekir.2023.09.024","volume":"8","author":"FWK Tam","year":"2023","unstructured":"Tam, F. W. K. et al. Randomized trial on the effect of an oral spleen tyrosine kinase inhibitor in the treatment of IgA nephropathy. Kidney Int. Rep. 8, 2546\u20132556 (2023).","journal-title":"Kidney Int. Rep."},{"key":"958_CR211","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1097\/TP.0000000000001826","volume":"101","author":"S Ramessur Chandran","year":"2017","unstructured":"Ramessur Chandran, S. et al. Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients. Transplantation 101, e240\u2013e248 (2017).","journal-title":"Transplantation"},{"key":"958_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06413-2","volume":"12","author":"S Tempest-Roe","year":"2022","unstructured":"Tempest-Roe, S. et al. Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization. Sci. Rep. 12, 3330 (2022).","journal-title":"Sci. Rep."},{"key":"958_CR213","unstructured":"US National Library of Medicine. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03991780 (2024)."},{"key":"958_CR214","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal. Transduct. Target. Ther. 8, 204 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"958_CR215","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","volume":"33","author":"KR Tuttle","year":"2018","unstructured":"Tuttle, K. R. et al. JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Nephrol. Dial. Transpl. 33, 1950\u20131959 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"958_CR216","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.ymthe.2018.07.014","volume":"26","author":"J Li","year":"2018","unstructured":"Li, J. et al. Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol. Ther. 26, 2523\u20132532 (2018).","journal-title":"Mol. Ther."},{"key":"958_CR217","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.kint.2016.03.035","volume":"90","author":"I Ludwig-Portugall","year":"2016","unstructured":"Ludwig-Portugall, I. et al. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney Int. 90, 525\u2013539 (2016).","journal-title":"Kidney Int."},{"key":"958_CR218","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.373","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. NLRP3 inflammasome of renal tubular epithelial cells induces kidney injury in acute hemolytic transfusion reactions. Clin. Transl. Med. 11, e373 (2021).","journal-title":"Clin. Transl. Med."},{"key":"958_CR219","doi-asserted-by":"publisher","first-page":"119974","DOI":"10.1016\/j.lfs.2021.119974","volume":"285","author":"MS Elsayed","year":"2021","unstructured":"Elsayed, M. S., Abu-Elsaad, N. M. & Nader, M. A. The NLRP3 inhibitor dapansutrile attenuates folic acid induced nephrotoxicity via inhibiting inflammasome\/caspase-1\/IL axis and regulating autophagy\/proliferation. Life Sci. 285, 119974 (2021).","journal-title":"Life Sci."},{"key":"958_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739953","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Hu, L., Xu, S., Ye, C. & Chen, A. Erianin: a direct NLRP3 inhibitor with remarkable anti-inflammatory activity. Front. Immunol. 12, 739953 (2021).","journal-title":"Front. Immunol."},{"key":"958_CR221","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/08923973.2023.2298894","volume":"46","author":"P Zhu","year":"2024","unstructured":"Zhu, P. et al. Thiolutin, a selective NLRP3 inflammasome inhibitor, attenuates cyclophosphamide-induced impairment of sperm and fertility in mice. Immunopharmacol. Immunotoxicol. 46, 172\u2013182 (2024).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"958_CR222","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"958_CR223","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1681\/ASN.2015111230","volume":"28","author":"J Voelker","year":"2017","unstructured":"Voelker, J. et al. Anti-TGF-\u03b21 antibody therapy in patients with diabetic nephropathy. J. Am. Soc. Nephrol. 28, 953\u2013962 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"958_CR224","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1042\/CS20180243","volume":"132","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Meng, X. M., Huang, X. R. & Lan, H. Y. The preventive and therapeutic implication for renal fibrosis by targetting TGF-\u03b2\/Smad3 signaling. Clin. Sci. 132, 1403\u20131415 (2018).","journal-title":"Clin. Sci."},{"key":"958_CR225","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103248","volume":"9","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. SARS-CoV-2 N protein induces acute kidney injury via smad3-dependent G1 cell cycle arrest mechanism. Adv. Sci. 9, e2103248 (2022).","journal-title":"Adv. Sci."},{"key":"958_CR226","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ymthe.2022.12.002","volume":"31","author":"W Wu","year":"2023","unstructured":"Wu, W. et al. Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest. Mol. Ther. 31, 344\u2013361 (2023).","journal-title":"Mol. Ther."},{"key":"958_CR227","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41392-023-01410-x","volume":"8","author":"L Liang","year":"2023","unstructured":"Liang, L. et al. SARS-CoV-2 N protein induces acute kidney injury in diabetic mice via the Smad3-Ripk3\/MLKL necroptosis pathway. Signal. Transduct. Target. Ther. 8, 147 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"958_CR228","doi-asserted-by":"publisher","first-page":"127396","DOI":"10.1016\/j.bmcl.2020.127396","volume":"30","author":"N Wu","year":"2020","unstructured":"Wu, N. et al. Discovery of a novel selective water-soluble SMAD3 inhibitor as an antitumor agent. Bioorg. Med. Chem. Lett. 30, 127396 (2020).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"958_CR229","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jcmm.14101","volume":"23","author":"LL Lv","year":"2019","unstructured":"Lv, L. L., Feng, Y., Tang, T. T. & Liu, B. C. New insight into the role of extracellular vesicles in kidney disease. J. Cell Mol. Med. 23, 731\u2013739 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"958_CR230","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1007\/s00467-024-06414-5","volume":"39","author":"J Li","year":"2024","unstructured":"Li, J. et al. Role of miRNAs in macrophage-mediated kidney injury. Pediatr. Nephrol. 39, 3397\u20133410 (2024).","journal-title":"Pediatr. Nephrol."},{"key":"958_CR231","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37515-8","volume":"14","author":"JY Chung","year":"2023","unstructured":"Chung, J. Y. et al. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nat. Commun. 14, 1794 (2023).","journal-title":"Nat. Commun."},{"key":"958_CR232","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nature06607","volume":"451","author":"JB Johnnidis","year":"2008","unstructured":"Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125\u20131129 (2008).","journal-title":"Nature"},{"key":"958_CR233","doi-asserted-by":"publisher","first-page":"155613","DOI":"10.1016\/j.metabol.2023.155613","volume":"146","author":"MC Oliveira","year":"2023","unstructured":"Oliveira, M. C. et al. Eosinophils protect from metabolic alterations triggered by obesity. Metabolism 146, 155613 (2023).","journal-title":"Metabolism"},{"key":"958_CR234","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2024.05.009","volume":"45","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Basophil differentiation, heterogeneity, and functional implications. Trends Immunol. 45, 523\u2013534 (2024).","journal-title":"Trends Immunol."},{"key":"958_CR235","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","volume":"19","author":"F Geissmann","year":"2003","unstructured":"Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71\u201382 (2003).","journal-title":"Immunity"},{"key":"958_CR236","doi-asserted-by":"publisher","first-page":"106421","DOI":"10.1016\/j.biocel.2023.106421","volume":"159","author":"W T\u2019Jonck","year":"2023","unstructured":"T\u2019Jonck, W. & Bain, C. C. The role of monocyte-derived macrophages in the lung: it\u2019s all about context. Int. J. Biochem. Cell Biol. 159, 106421 (2023).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"958_CR237","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka, K. & Banchereau, J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265\u2013277 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"958_CR238","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.immuni.2022.01.016","volume":"55","author":"J Feng","year":"2022","unstructured":"Feng, J. et al. Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells. Immunity 55, 405\u2013422.e11 (2022).","journal-title":"Immunity"},{"key":"958_CR239","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"958_CR240","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-60761-362-6_23","volume":"612","author":"YT Bryceson","year":"2010","unstructured":"Bryceson, Y. T. et al. Functional analysis of human NK cells by flow cytometry. Methods Mol. Biol. 612, 335\u2013352 (2010).","journal-title":"Methods Mol. Biol."},{"key":"958_CR241","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2018.03.008","volume":"42","author":"H Stabile","year":"2018","unstructured":"Stabile, H., Fionda, C., Santoni, A. & Gismondi, A. Impact of bone marrow-derived signals on NK cell development and functional maturation. Cytokine Growth Factor. Rev. 42, 13\u201319 (2018).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"958_CR242","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4049\/jimmunol.1601399","volume":"198","author":"MV Dhodapkar","year":"2017","unstructured":"Dhodapkar, M. V. & Kumar, V. Type II NKT cells and their emerging role in health and disease. J. Immunol. 198, 1015\u20131021 (2017).","journal-title":"J. Immunol."},{"key":"958_CR243","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350483","volume":"53","author":"A Waterholter","year":"2023","unstructured":"Waterholter, A., Wunderlich, M. & Turner, J. E. MAIT cells in immune-mediated tissue injury and repair. Eur. J. Immunol. 53, e2350483 (2023).","journal-title":"Eur. J. Immunol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00958-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T08:02:16Z","timestamp":1750406536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":243,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00958-x","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"24 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}